BioStorage Technologies opens new biorepository

Published: 27-May-2011
Logistics

To be used to prepare, store and transport human biological samples


Indianapolis, US-based BioStorage Technologies, a life sciences logistics specialist, has opened a new 60,000ft2 state-of-the-art biorepository facility in Indianapolis.

The US$4.6m facility, located near the Indianapolis International Airport, will be used to prepare, store and transport human biological samples.

‘This new facility provides the company with the infrastructure needed to support our continued growth and expanded services,’ said Greg Swanberg, chief executive of BioStorage Technologies.

BioStorage Technologies now has the ability to offer sample preparation services, including automated liquid handling technology to ensure the accuracy and precision needed for high-throughput DNA and RNA extraction and verification.

‘The future of drug discovery is in personalised medicine and genomic-based therapies, which will require an ability to store and analyse large quantities of tissue and blood samples,’ added Swanberg.

The new biorepository facility offers a range of storage options, including automated carousel controlled-room temperature and bulk sample storage at 15–27ºC, walk-in cold sample storage at –20ºC to 5ºC, ultra-low temperature storage at –70ºC to –80ºC, and –190ºC vapour phase liquid nitrogen.

  • Companies:
  • BioStorage Technologies
See more

You may also like

Digital

Marken and BioStorage Technologies form partnership in Singapore

Read more
Will provide full access to biological samples

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    The pros and cons of distribution agreements For life sciences companies seeking to break into overseas markets, distribution agreements are central to success
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Good pallet practice Are current pallets used for handling and transporting drugs and medicines the best they could be, or is there room for improvement? Jim Hardisty, MD, Goplasticpallets.com, takes a look at how some of the latest pallets are saving the industry time and money
  3. Lessons learned: AstraZeneca’s supply chain resilience during the pandemic With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
  4. RSSL responds to change in Good Distribution Practice guidelines Extra dates for courses covering the changes for distributors wishing to ensure their licence meets the new requirements
  5. FedEx Corp

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Digital

Marken and BioStorage Technologies form partnership in Singapore

Will provide full access to biological samples
Media

A year of challenges and innovation in pharma logistics lies head

Envirotainer CEO, Peter Gisel-Ekdahl, looks to the future and what 2022 holds for pharmaceutical logistics
Packaging

Dachser renews pharma certification in Frankfurt

Drugs and other pharmaceutical products are often temperature-sensitive, urgent shipments that must be handled in compliance with a complex regulatory environment
Pharmaceutical

Lessons learned: AstraZeneca’s supply chain resilience during the pandemic

With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
Digital

The human digital twin: a virtual counterpart to the human worker

Several organisations are familiar with making use of digital twin modelling to improve operations. This digitised model typically enables firms to map the physical characteristics of a production environment as well as its processes. But, this mapping process has limitations because it only includes data from machines and not from humans, which are crucial too
Regulatory

How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain

The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!
Digital

Addressing wastage and distribution challenges for a more equitable post-pandemic pharmaceutical industry

When functioning properly, globalised supply chains broaden access to critical medicines for billions of individuals all over the world. Yet, any number of issues, from macro events such as the recent COVID-19 pandemic or the 2010 volcanic eruption in Iceland, through to more simple patient misunderstandings, can lead to expensive and often unnecessary wastage
Subscribe now